Author Archive: Daniel Seaton

Daniel Seaton

Daniel Seaton is Manager of Event & Health Communications, working on communications for BIO’s events and health care policy issues. Prior to joining BIO in August 2013, he spent four years in communications at the Pharmaceutical Research and Manufacturers of America. The best part of his job is educating audiences about the many benefits the bioscience industry produces for patients, consumers, and the economy as a whole. Daniel enjoys hiking, camping, and, when he can find a game, playing bridge. Having grown up in New Mexico, one of his favorite foods is roasted green chile. He recently completed a Master’s degree in communications at Georgetown University.

Latest Posts

Vote for the Buzz of BIO at BIF 2015

BuzzofBIOLogo

Voting is now open for the Buzz of BIO at the 2015 BIO Investor Forum. The Buzz of BIO contest recognizes highly innovative companies in the biotech sector and helps position these companies to develop strategic partnerships within the industry. One winner will be chosen from each of two categories: “Early Stage Entrepreneurs” and “Late Stage Leaders”. You can vote once per day in each category from now until Friday, August 28 at 5 p.m. Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

Nominations Open: Be the Buzz of BIO at the 2015 BIO Investor Forum

Buzz of BIO contest, BIO Investor Forum

Nominations are now open for the Buzz of BIO at the 2015 BIO Investor Forum. The Buzz of BIO contest recognizes highly innovative companies in the biotech sector and helps position these companies to develop strategic partnerships within the industry. Ten biotechs will be nominated in each of two categories – Early Stage Entrepreneurs and Late Stage Leaders. Winners will then be chosen via online vote from August 24-28. The contest is an excellent opportunity for early-stage Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: ,

Jim Greenwood asks: How prepared are we for avian flu?

Jim Greenwood

As a serious avian influenza outbreak continues to wreak havoc on poultry farms across the U.S., one question that is beginning to draw attention from lawmakers and others centers on our ability to respond should the virus begin to infect humans. BIO President and CEO Jim Greenwood explored that issue in an op-ed yesterday at The Hill: The prospect of HPAI [Highly Pathogenic Avian Influenza] spreading to humans recently drew the attention of bipartisan leaders Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , ,

Missed #BIO2015? There’s an app for that.

bio2015 virtual attendee package

If you missed out on BIO 2015 in Philadelphia last month – or didn’t get the chance to go to all the sessions you wanted – I’ve got the solution for you. For the first time ever, select educational programming is now available in our Virtual Attendee Package, featuring sessions from tracks including Business Development & Finance, Digital Health, Oncology, Infectious Disease, Personalized Medicine & Diagnostics, and more. You’ll be able to hear from speakers Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

BIO Innovation Zone Company Snapshots: AreteX Engineering

BIO Innovation Zone

This month in Philadelphia at the BIO International Convention, BIO will be partnering with the National Science foundation (NSF) and the National Institutes of Health (NIH) to host the 2nd annual, newly-expanded BIO Innovation Zone. The Zone will feature Small Business Innovation Research (SBIR) funded early-stage biotech companies. The SBIR/STTR program provides U.S. federal funding to small businesses engaged in research with the potential for commercialization. Each of the companies has been rigorously vetted through the SBIR/STTR review process Read More >

Business and Investments, Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,